What Tiziana Life Sciences Ltd's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 5 | 5 |
| Sells | 0 | 0 |
| Total trades | 6 | 6 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 1,088,137 | 1,088,137 |
| Disposed | 0 | 0 |
| Net activity | +1,088,137 | +1,088,137 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Elrifi Ivor | Chief Executive Officer | Aug 05 | Open-market buy · P | +237,616 | $1.00 | +$238K | 4,793,684 |
| Elrifi Ivor | Chief Executive Officer | Aug 04 | Open-market buy · P | +83,807 | $0.97 | +$81.3K | 4,556,068 |
| Elrifi Ivor | Chief Executive Officer | Aug 03 | Open-market buy · P | +667,000 | $1.00 | +$667K | 4,472,261 |
| Cerrone Gabriel M | Director | Jul 21 | Open-market buy · P | +42,357 | $0.99 | +$41.9K | 44,814,587 |
| Cerrone Gabriel M | Director | Jul 21 | Grant / award · A | +42,357 | $0.99 | +$41.9K | 44,814,587 |
| Cerrone Gabriel M | Director | Jun 12 | Open-market buy · P | +15,000 | $1.11 | +$16.7K | 44,772,230 |
Loading...
